DETECTION OF CANCER CELLS ADDED TO BLOOD SAMPLES TAKEN FROM HEALTHY INDIVIDUALS

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。治愈某些癌症的最好机会是在早期阶段发现它们，并实施适当的手术和辅助治疗。开发一种可以有效识别早期癌症的测试方法有可能极大地改善患者的预后。这项研究的目标是通过免疫磁性细胞浓缩的方法来检测健康献血者血液中添加的稀有细胞。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The best chance for a cure of some cancers occurs when they are detected at an early stage and appropriate surgical and adjuvant therapies are administered. Developing a test which could effectively identify early stage cancers has the potential to greatly improve patient outcomes. The goal of this study is to detect rare cells spiked in the blood of healthy donors by means of immuno-magnetic cell enrichment.